Wenping Zhou

Wenping Zhou is an experienced equity research associate currently working at Cantor Fitzgerald since September 2023. Prior to this role, Wenping served as a senior research associate at Evercore from August 2022 to September 2023. Additional experience includes serving as a board observer for multiple organizations, including Enrich Therapeutics Inc., RevMedica, Inc., Thetis Pharmaceuticals, Avitus Orthopaedics, CytoVeris Inc., BiologicsMD, Inc., Bactana Corp., and Azitra Inc. from July 2020 to August 2022. Wenping Zhou holds a PhD in Cell/Cellular and Molecular Biology from Yale University, as well as a Bachelor of Science in Biology from Nanjing University and a Global Study Program in Biology from the University of California, Davis.